posted on 2023-03-31, 03:01authored byChen Jiang, Lei Li, Yan-Qun Xiang, Maria Li Lung, Tingting Zeng, Jiabin Lu, Sai Wah Tsao, Mu-Sheng Zeng, Jing-Ping Yun, Dora L.W. Kwong, Xin-Yuan Guan
<p>Supplementary Figure 3 (a) CNE2 were transiently transfected with control mimic (Cel- 39), BART2-5p mimic, BART2-5p mimic + pcDNA3.1Vec, BART2-5p mimic + RND3 or BART2-5p and Y-27632 treatment. For control cells and BART2-5p transfected cells, F-Actin staining was performed to visualize stress fiber formation at 6 h after transfection. For cells transfected by BART2-5p and pcDNA3.1Vec or RND3 expressing vector, vector or RND3 was transfected 24 h earlier than transfection of BART2-5p to allow gene expression in cells. Pictures were taken at 6 h after transfection of BART2-5p. 1μM ROCK inhibitor Y-27632 was added to culture medium for a 15min incubation at 6 h after transfection of BART2-5p before fixation. (b) CNE2 cells with BART2 expression or RND3 knock down were lysed for Western Blot. Either BART2 overexpression or RND3 knock down led to increased phosphorylated MLC2 and MYPT1. (c) Western Blot shows induced activation of ROCK signaling by BART2 in CNE2 cells could be abolished by reinstatement of RND3 or Y-27632 treatment. (d) Images of Western Blot show alteration of key components in ROCK signaling pathway in siBART2-5p transfected or RND3 overexpressed HONE-1 EBV (+/-) cells.</p>
Nasopharyngeal carcinoma is an Epstein–Barr virus (EBV)-related malignancy. Recently, we found that the EBV-encoded miRNA BART2-5p was increased in the serum of patients with preclinical nasopharyngeal carcinoma and that the copy number positively correlated with disease progression. In this study, we established its role in nasopharyngeal carcinoma progression and explored underlying mechanisms and clinical significance. BART2-5p was an independent unfavorable prognostic factor for progression-free survival and its circulating abundance positively associated with distant metastasis. Ectopic expression of BART2-5p promoted migration and invasion of EBV-negative nasopharyngeal carcinoma cells, whereas genetic downregulation of BART2-5p in EBV-positive nasopharyngeal carcinoma cells decreased aggressiveness. Mechanistically, BART2-5p targeted RND3, a negative regulator of Rho signaling. Downregulation of RND3 phenocopied the effect of BART2-5p and reconstitution of RND3 rescued the phenotype. By suppressing RND3, BART2-5p activated Rho signaling to enhance cell motility. These findings suggest a novel role for EBV miRNA BART2-5p in promoting nasopharyngeal carcinoma metastasis and its potential value as a prognostic indicator or therapeutic target.
This study shows that EBV-encoded BART2-5p miRNA suppresses expression of the RND3 Rho family GTPase, consequently promoting ROCK signaling, cell motility, and metastatic behavior of NPC cells.